Irving, Texas, October 15, 2026 / PRNewswire / -- Leading TechBio company Caris Life Sciences (Nasdaq ticker: CAI) announced today that it will release its financial results for the third quarter of 2026 on Wednesday, November 4, 2026.
Caris Life Sciences will hold a live webcast at 3:30 PM Central Time (4:30 PM Eastern Time) to discuss financial results.
Live Streaming Details:
- Date: Wednesday, November 4, 2026
- Time: 3:30 PM Central Time (4:30 PM Eastern Time)
- Live broadcast link: https :// edge.media-server.com / mmc /p/ nri9afky
Shortly after this teleconference concludes, the live broadcast replay will be available in the Investor Relations section of the Caris Life Sciences official website, with the URL being CarisLifeSciences.com.
About Caris Life Sciences
Caris Life Sciences ( Caris ) is a leading TechBio company that is actively developing and commercializing innovative solutions to drive healthcare transformation. Through comprehensive molecular analysis (whole-genome, whole-exome, and whole-transcriptome sequencing), advanced artificial intelligence, and machine learning, Caris has established large-scale, multi-modal clinical genomics databases and computational capabilities to analyze and further reveal the molecular complexity of diseases. The company states that the integration of next-generation sequencing, artificial intelligence, machine learning technologies, and high-performance computing constitutes a differentiated platform for developing a new generation of advanced precision medical diagnosis solutions, covering early detection, diagnosis, monitoring, treatment selection, and drug development.
Caris indicates that the company's vision upon its establishment is to realize the potential of precision medicine in order to improve the human condition. Caris Headquartered in Irvine, Texas, the company has offices in Phoenix, New York, Cambridge, Massachusetts, Tokyo, Japan, and Basel, Switzerland. Caris or its distribution partners provide services in the United States and other international markets.
Caris Life Sciences Media Contact:
Corporate Communications Department[ email protected ]214.294.5606Investor Relations:
[ email protected ]917.689.3511









